These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29408926)

  • 1. Mid-to-long term mortality following surgical versus percutaneous coronary revascularization stratified according to stent subtype: An analysis of 6,682 patients with multivessel disease.
    Raja SG; Ilsley C; De Robertis F; Lane R; Kabir T; Bahrami T; Simon A; Popov A; Dalby MC; Mason M; Grocott-Mason R; Smith RD; Iqbal MB
    PLoS One; 2018; 13(2):e0191554. PubMed ID: 29408926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis.
    Raja SG; Benedetto U; Ilsley CD; Amrani M;
    Int J Cardiol; 2015; 189():153-8. PubMed ID: 25897895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.
    Habib RH; Dimitrova KR; Badour SA; Yammine MB; El-Hage-Sleiman AK; Hoffman DM; Geller CM; Schwann TA; Tranbaugh RF
    J Am Coll Cardiol; 2015 Sep; 66(13):1417-27. PubMed ID: 26403338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Outcomes of Coronary Artery Bypass Grafting Using Internal Mammary Graft Versus Percutaneous Coronary Intervention for Isolated Proximal Left Anterior Descending Narrowing.
    Iqbal MB; Ilsley C; De Robertis F; Lane R; Kabir T; Bahrami T; Simon A; Popov A; Amrani M; Dalby MC; Mason M; Grocott-Mason R; Smith RD; Raja SG
    Am J Cardiol; 2017 Mar; 119(5):719-726. PubMed ID: 28038726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with percutaneous coronary interventions.
    Locker C; Schaff HV; Daly RC; Dearani JA; Bell MR; Frye RL; Greason KL; Stulak JM; Joyce LD; Pochettino A; Li Z; Lennon RJ; Lerman A
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):369-379.e4. PubMed ID: 27174511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year improved survival in patients with multi-vessel coronary disease and poor left ventricular function following surgery: A retrospective cohort study.
    Cummings IG; Lucchese G; Garg S; Soni M; Majid AF; Marczin N; Panoulas V; Raja SG
    Int J Surg; 2020 Apr; 76():146-152. PubMed ID: 32173612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.
    Mina GS; Watti H; Soliman D; Shewale A; Atkins J; Reddy P; Dominic P
    Cardiovasc Revasc Med; 2018 Sep; 19(6):671-678. PubMed ID: 29396239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes following drug-eluting stents versus bare metal stents for primary percutaneous coronary intervention: A real-world analysis of 11,181 patients from the british columbia cardiac registry.
    Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Robinson SD; Siega AD;
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):24-35. PubMed ID: 26945680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.
    Aggarwal V; Stanislawski MA; Maddox TM; Nallamothu BK; Grunwald G; Adams JC; Ho PM; Rao SV; Casserly IP; Rumsfeld JS; Brilakis ES; Tsai TT
    J Am Coll Cardiol; 2014 Oct; 64(17):1825-36. PubMed ID: 25443706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention.
    Hlatky MA; Boothroyd DB; Baker LC; Go AS
    Am Heart J; 2015 Jan; 169(1):149-54. PubMed ID: 25497260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    Chang M; Ahn JM; Lee CW; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    J Am Coll Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 27364047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.
    Ariyaratne TV; Yap CH; Ademi Z; Rosenfeldt F; Duffy SJ; Billah B; Reid CM
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):261-270. PubMed ID: 29474722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
    Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials.
    Benedetto U; Gaudino M; Ng C; Biondi-Zoccai G; D'Ascenzo F; Frati G; Girardi LN; Angelini GD; Taggart DP
    Int J Cardiol; 2016 May; 210():19-24. PubMed ID: 26922707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-generation drug-eluting stenting versus coronary artery bypass grafting for treatment of coronary chronic total occlusion.
    Jang WJ; Yang JH; Song YB; Hahn JY; Chun WJ; Oh JH; Kim WS; Lee YT; Yu CW; Lee HJ; Gwon HC; Choi SH
    J Cardiol; 2019 May; 73(5):432-437. PubMed ID: 30611686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bypass confers intermediate-term survival benefit over percutaneous coronary intervention with new-generation stents in real-world patients with multivessel coronary artery disease, including left main disease: a retrospective analysis of 6383 patients.
    Panoulas VF; Ilsley CJ; Kalogeras K; Khan H; Monteagudo Vela M; Dalby M; Kabir T; Smith RD; Mason M; Grocott-Mason R; Cummings I; Lüscher TF; Raja SG
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):911-918. PubMed ID: 31079151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.
    De Luca G; Schaffer A; Verdoia M; Suryapranata H
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):344-54. PubMed ID: 24373711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.